about
A Review of Dietary Influences on Cardiovascular Health: Part 2: Dietary PatternsRenal endothelial dysfunction in acute kidney ischemia reperfusion injuryRenal endothelial dysfunction in diabetic nephropathyMechanical ventilation for ARDS patients--for a better understanding of the 2012 Surviving Sepsis Campaign GuidelinesSepsis pathophysiology and anesthetic considerationEvaluation and management of atrial fibrillationAnti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion moleculesRho-signaling pathways in chronic myelogenous leukemia.The metabolic syndrome and vascular disease in Asia.Extracorporeal lung assist for sepsis and acute respiratory distress syndrome.The effects of prostaglandin E-1 in patients with intermittent claudication.Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.The role of tirofiban in the management of coronary artery disease.Fc-independent phagocytosis: implications for intravenous IgG therapy in immune thrombocytopenia.Thrombotic microangiopathies: towards a pathophysiology-based classification.Thrombotic microangiopathy and occult neoplasia.Fc-independent phagocytosis: implications for IVIG and other therapies in immune-mediated thrombocytopenia.Is there any role for splenectomy in adulthood onset chronic immune thrombocytopenia in the era of TPO receptors agonists? A critical overview.Expressions of eNOS3 and Ve-cadherin in microvascular endothelium at 7-day of reperfused acute myocardial infarction.Paradoxical thrombotic effects of aspirin: experimental study on 1000 animals.Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis.Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases.Antiproliferative and proapoptotic effects of proteasome inhibitors and their combination with histone deacetylase inhibitors on leukemia cells.The efficacy and safety of cilnidipine on mild to moderate essential hypertension: a systematic review and meta-analysis of randomized controlled trials in Chinese patients.Human embryonic stem cell-derived cardiomyocytes for heart therapies.Promising therapies in sickle cell disease.Red cell glycolytic enzyme disorders caused by mutations: an update.A review of dietary influences on cardiovascular health: part 1: the role of dietary nutrients.Atherosclerosis-related functions of C-reactive protein.Statins for early stage chronic kidney disease: an overview of reviews.Reactive oxygen species in vascular wall.Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease.The use of carvedilol in pediatric heart failure.The antiplatelet drug target in atherosclerotic diseases.Hypertension and counter-hypertension mechanisms in giraffes.Cyclooxygenase-2 inhibitors: a painful lesson.Regulatory mechanisms of cardiac development and repair.Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction?Physiological significance and therapeutic potential of adrenomedullin in pulmonary hypertension.
P1433
Q22241318-62650C94-04C1-4996-8015-47A8362E11FFQ26859947-3449AB94-B777-495A-93EC-418C22D87F9DQ27021318-47890D64-DDCB-48FC-8FED-B8420C8C5F87Q28080672-195833F3-8968-44F7-A534-1EA83976CE48Q28084129-ADBBAE8D-406D-4C21-B905-AF2836B3A827Q28221313-59AE5930-48A6-46F4-ADF3-41DBE0803105Q28221317-3B971D3A-3D69-478F-94B2-7C35B39314E0Q30157446-2DF37EEC-0BC0-4BAE-B540-A668612F188FQ30362487-787B1636-66CE-4FBB-8104-B1E5E5C20DF3Q30370524-D95B33CD-9371-42EF-B29C-E0055FD9A342Q33247329-D096D439-DB11-4CF2-BACB-599288E827F3Q33376816-637CAE0D-5ADC-4C1F-B5F6-D661A4507A2AQ33379905-21010387-DA70-45EE-8CA3-225D120D0BD2Q33382400-0B5BD3D8-5F23-46AB-B516-BE80508C7675Q33383642-0E5A33F4-2B76-43CF-AA43-D837610AF9C8Q33389176-11FC5757-A95C-4A6B-9905-0B2F4CB773B2Q33403925-EBB1DAD5-28F2-4D21-B6AA-075AC144FCF7Q33437984-07DDD56A-4E4D-455F-B1CF-5C26095B4958Q33466437-9A450274-2573-4249-8ACD-48D8320DB448Q33547160-0665A3B0-7027-49CE-8499-89709EB055BDQ33793455-02A3378A-4F07-40C3-BBE2-74605442B558Q34038874-89B641AA-8C0A-4601-99F8-70C1783F83B5Q34482973-7C7DAF03-5F7E-4FDE-939E-38A5F3F4C37FQ34605264-8868493A-6F87-4032-A779-3267B9B08AB4Q34639788-F013C91D-FAAE-471D-8709-B8677D116AF6Q34640287-72B141DA-B2DF-4298-A7DC-AA6C3F31D994Q34960390-060FD792-DFB2-4A0D-9D8F-E7CA5C783F04Q34986259-74FC0203-47FB-4A47-9AF4-4DA1022D0D04Q35058807-A5063780-DE6E-459E-9A6C-2C6056D6921AQ35073552-BF0CEEE3-0FB2-4CFD-9717-16B8C69456E9Q35144534-EE6120E0-9C7C-49B9-A0A1-9E2C12F52D2EQ36489220-53AFF1D3-FC2B-4796-96B7-9115F547D088Q36489226-F9D5C857-5D67-44C6-AF4C-694C77A86A1EQ36489230-8DF1B18F-23A5-4836-8974-42F3953CC39BQ36489235-D4C6CA49-C270-4D19-8033-391D86208804Q36489240-5E32947A-6CB8-48E2-9972-59AC5815AEF1Q36512725-8665D728-33C2-4BA2-A7EB-D7223FAB40CAQ36512730-4D9DBDB1-F1BE-4C6A-974E-D7BF2B854FB3Q36512733-D25F1D7C-6E2C-4EDE-BC6F-968C202708AAQ36512737-F6EA0827-87CA-45BF-95AC-88AF463EFDE3
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Bentham Science Publishers
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Cardiovascular & hematological disorders drug targets
@ast
Cardiovascular & hematological disorders drug targets
@en
Cardiovascular & hematological disorders drug targets
@es
Cardiovascular & hematological disorders drug targets
@it
Cardiovascular & hematological disorders drug targets
@nl
type
label
Cardiovascular & hematological disorders drug targets
@ast
Cardiovascular & hematological disorders drug targets
@en
Cardiovascular & hematological disorders drug targets
@es
Cardiovascular & hematological disorders drug targets
@it
Cardiovascular & hematological disorders drug targets
@nl
prefLabel
Cardiovascular & hematological disorders drug targets
@ast
Cardiovascular & hematological disorders drug targets
@en
Cardiovascular & hematological disorders drug targets
@es
Cardiovascular & hematological disorders drug targets
@it
Cardiovascular & hematological disorders drug targets
@nl
P3181
P1055
P1156
4600151526